uiring diabetes unprecedented freedom, comfort and ease in
managing their diabetes. The System consists of two devices, the compact,
lightweight OmniPod, which is worn discreetly beneath clothing and delivers
precise, personalized doses of insulin based on instructions programmed
wirelessly using its companion, the handheld, wireless Personal Diabetes
Manager (PDM). The OmniPod features no tubing and virtually pain-free
automated insertion. The PDM, which is very similar in look and feel to a
personal digital assistant, features an integrated blood glucose meter,
disease management software and integrated storage of all insulin delivery,
blood glucose and carbohydrate records.
About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated
to improving the lives of people with diabetes. The Company's OmniPod
Insulin Management System is a revolutionary, discreet and easy-to-use
insulin infusion system that features two easy-to-use parts with no tubing
and fully-automated cannula insertion. Through the OmniPod System, Insulet
seeks to expand the use of continuous subcutaneous insulin infusion (CSII)
therapy among people with insulin-requiring diabetes. Founded in 2000,
Insulet is based in Bedford, MA.
Contacts:
Rachel Kessler, Lazar Partners
(917) 660-0608
pr@insulet.com
Mark Sahl, Lazar Partners
(646) 871-8485
video@myomnipod.com
'/>"/>SOURCE Insulet Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Video: OneTouch(R) Teams With Online Diabetes Community to Launch Global Diabetes Handprint Project2.
Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent3.
Video: Women Unsatisfied With Body and Breasts, Less Likely to Comply With Screenings, Including Mammography4.
Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder5.
Video: Fortune 1000 Executives: New President Must Fix Education Gap6.
Video: Keppra XR(TM) Approved in the U.S.7.
Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School8.
Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 119.
Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder10.
Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech11.
Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia